HILTONOL PROTOCOL (PHASE II) 

Project objectives

Randomized study in patients suffering from advanced epithelial carcinoma of ovarian, tubal or peritoneal origin, on the efficacy of standard first line chemotherapy associated with Oregovomab + Hiltonol ® versus standard therapy alone.

Start and end date

Project Manager

Coordinating institution of the project